201 related articles for article (PubMed ID: 31948845)
1. Identification of potent pyrazole based APELIN receptor (APJ) agonists.
Narayanan S; Vasukuttan V; Rajagopal S; Maitra R; Runyon SP
Bioorg Med Chem; 2020 Feb; 28(4):115237. PubMed ID: 31948845
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel small molecule agonist scaffold for the APJ receptor.
Narayanan S; Maitra R; Deschamps JR; Bortoff K; Thomas JB; Zhang Y; Warner K; Vasukuttan V; Decker A; Runyon SP
Bioorg Med Chem; 2016 Aug; 24(16):3758-70. PubMed ID: 27369451
[TBL] [Abstract][Full Text] [Related]
3. Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice.
Narayanan S; Wang S; Vasukuttan V; Vyas Devambatla RK; Dai D; Jin C; Snyder R; Laudermilk L; Runyon SP; Maitra R
J Med Chem; 2021 Mar; 64(6):3006-3025. PubMed ID: 33705126
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor.
Narayanan S; Dai D; Vyas Devambatla RK; Albert V; Bruneau-Latour N; Vasukuttan V; Ciblat S; Rehder K; Runyon SP; Maitra R
Bioorg Med Chem; 2022 Jul; 66():116789. PubMed ID: 35594649
[TBL] [Abstract][Full Text] [Related]
7. Elabela/Toddler and apelin bind differently to the apelin receptor.
Couvineau P; Llorens-Cortes C; Iturrioz X
FASEB J; 2020 Jun; 34(6):7989-8000. PubMed ID: 32301550
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
[TBL] [Abstract][Full Text] [Related]
9. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
Kuba K; Sato T; Imai Y; Yamaguchi T
Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
[TBL] [Abstract][Full Text] [Related]
10. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.
Read C; Nyimanu D; Williams TL; Huggins DJ; Sulentic P; Macrae RGC; Yang P; Glen RC; Maguire JJ; Davenport AP
Pharmacol Rev; 2019 Oct; 71(4):467-502. PubMed ID: 31492821
[TBL] [Abstract][Full Text] [Related]
11. Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ.
Myers MC; Bilder DM; Cavallaro CL; Chao HJ; Su S; Burford NT; Nayeem A; Wang T; Yan M; Langish RA; Dabros M; Li YX; Rose AV; Behnia K; Onorato JM; Gargalovic PS; Wexler RR; Lawrence RM
Bioorg Med Chem Lett; 2020 Apr; 30(7):126955. PubMed ID: 32035698
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
[TBL] [Abstract][Full Text] [Related]
13. Targeting Apelinergic System in Cardiometabolic Disease.
Guo R; Rogers O; Nair S
Curr Drug Targets; 2017; 18(15):1785-1791. PubMed ID: 27296311
[TBL] [Abstract][Full Text] [Related]
14. Cardiac action of the first G protein biased small molecule apelin agonist.
Read C; Fitzpatrick CM; Yang P; Kuc RE; Maguire JJ; Glen RC; Foster RE; Davenport AP
Biochem Pharmacol; 2016 Sep; 116():63-72. PubMed ID: 27475715
[TBL] [Abstract][Full Text] [Related]
15. Biphenyl Acid Derivatives as APJ Receptor Agonists.
Su S; Clarke A; Han Y; Chao HJ; Bostwick J; Schumacher W; Wang T; Yan M; Hsu MY; Simmons E; Luk C; Xu C; Dabros M; Galella M; Onorato J; Gordon D; Wexler R; Gargalovic PS; Lawrence RM
J Med Chem; 2019 Nov; 62(22):10456-10465. PubMed ID: 31724863
[TBL] [Abstract][Full Text] [Related]
16. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
17. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
18. The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?
Respekta N; Pich K; Dawid M; Mlyczyńska E; Kurowska P; Rak A
Cells; 2022 Dec; 12(1):. PubMed ID: 36611944
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles.
Jiang Y; Yan M; Wang C; Wang Q; Chen X; Zhang R; Wan L; Ji B; Dong B; Wang H; Chen J
Front Pharmacol; 2021; 12():630548. PubMed ID: 33746758
[TBL] [Abstract][Full Text] [Related]
20. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
